Angeletti Andrea, Cantarelli Chiara, Riella Leonardo V, Fribourg Miguel, Cravedi Paolo
Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children's Hospital, Genoa, Italy.
Dipartimento di Medicina e Chirurgia, Università di Parma; UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Transplantation. 2022 Mar 1;106(3):489-499. doi: 10.1097/TP.0000000000003851.
Exhaustion of T cells occurs in response to long-term exposure to self and foreign antigens. It limits T cell capacity to proliferate and produce cytokines, leading to an impaired ability to clear chronic infections or eradicate tumors. T-cell exhaustion is associated with a specific transcriptional, epigenetic, and metabolic program and characteristic cell surface markers' expression. Recent studies have begun to elucidate the role of T-cell exhaustion in transplant. Higher levels of exhausted T cells have been associated with better graft function in kidney transplant recipients. In contrast, reinvigorating exhausted T cells by immune checkpoint blockade therapies, while promoting tumor clearance, increases the risk of acute rejection. Lymphocyte depletion and high alloantigen load have been identified as major drivers of T-cell exhaustion. This could account, at least in part, for the reduced rates of acute rejection in organ transplant recipients induced with thymoglobulin and for the pro-tolerogenic effects of a large organ such as the liver. Among the drugs that are widely used for maintenance immunosuppression, calcineurin inhibitors have a contrasting inhibitory effect on exhaustion of T cells, while the influence of mTOR inhibitors is still unclear. Harnessing or encouraging the natural processes of exhaustion may provide a novel strategy to promote graft survival and transplantation tolerance.
T细胞耗竭是机体长期暴露于自身和外来抗原时的一种反应。它限制了T细胞增殖和产生细胞因子的能力,导致清除慢性感染或根除肿瘤的能力受损。T细胞耗竭与特定的转录、表观遗传和代谢程序以及特征性细胞表面标志物的表达相关。最近的研究已开始阐明T细胞耗竭在移植中的作用。在肾移植受者中,较高水平的耗竭T细胞与更好的移植物功能相关。相反,通过免疫检查点阻断疗法恢复耗竭T细胞活力,虽能促进肿瘤清除,但会增加急性排斥反应的风险。淋巴细胞耗竭和高同种异体抗原负荷已被确定为T细胞耗竭的主要驱动因素。这至少可以部分解释使用抗胸腺细胞球蛋白诱导的器官移植受者急性排斥反应发生率降低的原因,以及像肝脏这样的大器官所具有的促耐受作用。在广泛用于维持免疫抑制的药物中,钙调神经磷酸酶抑制剂对T细胞耗竭具有相反的抑制作用,而雷帕霉素靶蛋白抑制剂的影响仍不明确。利用或促进自然的耗竭过程可能为提高移植物存活率和移植耐受性提供一种新策略。